Pharmaceutical PV DIV - FSB

Ended Indefinite Delivery Contract Awarded

Contract number
SPE2DB24D9644
Awardee
Awarding agency
Task orders
14 $257,146 obligated

Award facts

Opportunity
  • SPM2DP13R0007 Solicitation number
Combined order value
$257,146 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 5% used
$4,999,999.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This IDC contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a broad range of pharmaceutical products and medical supplies to support the recurring needs of military health facilities worldwide. The single-award, $499,999,999 indefinite delivery contract (IDC) under the SPE2DB program allows DLA to issue firm fixed-price delivery orders for a comprehensive portfolio of medications, including branded and generic prescription drugs, over-the-counter products, biologics, and medical consumables. This IDC complements DMS Pharmaceutical Group's existing prime vendor contracts for direct pharmaceutical distribution and pharmacy services to Department of Defense (DoD) sites. Through this contract, DMS Pharmaceutical Group supplies an extensive array of pharmaceutical items, such as flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications, to support the diverse medical requirements of military personnel and their dependents across DoD healthcare facilities. The contract has a period of performance through December 31, 2025, with no set-aside designation.

Task orders

Task order Ordering agency Obligated Awarded
Xtandi 80 MG tablet 60S SPE2DB25FLGNY Defense Logistics Agency $23,366
Entyvio 300 MG vials SPE2DB25FLGNX Defense Logistics Agency $41,567
Xtandi 80 MG tablet 60S SPE2DB25FLGNW Defense Logistics Agency $11,683
Nova max glucose test strip 50S SPE2DB25FLGNT Defense Logistics Agency $95
Armour thyroid 120 MG tablet 100S SPE2DB25FLGNU Defense Logistics Agency $1,471
Nucala 100 MG/ML auto-injectorml SPE2DB25FLGNS Defense Logistics Agency $10,608
Nucala 100 MG/ML auto-injectorml SPE2DB25FLGNR Defense Logistics Agency $5,304
Nexplanon 68 MG implants SPE2DB25FLGNQ Defense Logistics Agency $50,063
Mirena 52 MG systems SPE2DB25FLGNP Defense Logistics Agency $41,469
Vitamin b-6 50 MG tablet 100S SPE2DB25FLGNM Defense Logistics Agency $9
Epinephrine 0.3 MG auto-inject 2S SPE2DB24FLGNX Defense Logistics Agency $1,397
Xtandi 80 MG tablet 60S SPE2DB24FLGNP Defense Logistics Agency $46,732
Xtandi 80 MG tablet 60S SPE2DB24FLGNN Defense Logistics Agency $23,366
Pharbetol 325 MG tablet 1000S SPE2DB24FLGNM Defense Logistics Agency $17
Show all 14

Quick answers

Who was awarded contract SPE2DB24D9644?

SPE2DB24D9644 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 18, 2024.

How much is contract SPE2DB24D9644 worth?

Orders under SPE2DB24D9644 have obligated $257,146. SPE2DB24D9644's own ceiling is $4,999,999.

How many orders have been placed under contract SPE2DB24D9644?

14 orders have been placed under SPE2DB24D9644, the latest on August 22, 2025.

Who can order from contract SPE2DB24D9644?

SPE2DB24D9644 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract SPE2DB24D9644 competed?

The extent of competition for SPE2DB24D9644 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV